Solvent-dependent precipitation of prion protein (Q43992119)

28 November 2017

Solvent-dependent precipitation of prion protein (English)

1 reference

28 November 2017

0 references

Kang Cai

1

1 reference

28 November 2017

Jeanette L C Miller

2

1 reference

28 November 2017

Christopher J Stenland

3

1 reference

28 November 2017

Kevin J Gilligan

4

1 reference

28 November 2017

Randal C Hartwell

5

1 reference

28 November 2017

Jarrett C Terry

6

1 reference

28 November 2017

Rosemary B Evans-Storms

7

1 reference

28 November 2017

Richard Rubenstein

8

1 reference

28 November 2017

Stephen R Petteway

9

1 reference

28 November 2017

Douglas C Lee

10

1 reference

28 November 2017

1 May 2002

1 reference

Biochimica et Biophysica Acta

28 November 2017

1 reference

28 November 2017

1597

1 reference

28 November 2017

1

1 reference

28 November 2017

28-35

1 reference

The transmissible spongiform encephalopathies

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Identification of a protein that purifies with the scrapie prion.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Immunoaffinity purification and neutralization of scrapie prion infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

1 reference

7 January 2021

Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Folding of prion protein to its native alpha-helical conformation is under kinetic control

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Protein misfolding and prion diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Scrapie agent contains a hydrophobic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Scrapie prions aggregate to form amyloid-like birefringent rods

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Separation and properties of cellular and scrapie prion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Reversibility of scrapie-associated prion protein aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

A protease-resistant protein is a structural component of the scrapie prion.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Properties of the scrapie prion protein: quantitative analysis of protease resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Prion proteins carrying pathogenic mutations are resistant to phospholipase cleavage of their glycolipid anchors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

1 reference

7 January 2021

Molecular mass, biochemical composition, and physicochemical behavior of the infectious form of the scrapie precursor protein monomer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Prions and blood products

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and beta1-lipoprotein into subfractions of human plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Solubility as a function of protein structure and solvent components

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Sedimentation properties of the scrapie agent

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Thiocyanate and hydroxyl ions inactivate the scrapie agent

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Mapping the early steps in the pH-induced conformational conversion of the prion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

On the mechanism of the cold ethanol precipitation method of plasma protein fractionation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Binding of disease-associated prion protein to plasminogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Transmission of BSE by blood transfusion in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2802%2900282-0

7 January 2021

10.1016/S0167-4838(02)00282-0

Identifiers

DOI

1 reference

28 November 2017

1 reference